In this issue of Cell Chemical Biology, Geng and colleagues employ a novel mouse model of humanized cereblon (Crbn) to provide insights into the immunomodulatory effects of lenalidomide and provide rationale for potential therapeutic combinations including anti-PD1 immunotherapy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.chembiol.2022.07.004 | DOI Listing |
Publication Analysis
Top Keywords
repurposing repurposed
4
repurposed thalidomide
4
thalidomide analogs
4
analogs immune
4
immune stimulants
4
stimulants overcome
4
overcome t cell
4
t cell exhaustion
4
exhaustion issue
4
issue cell
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!